{
  "fullName": "Young-Soo Lee",
  "slug": "young-soo-lee",
  "title": "MD",
  "specialty": "Oncology",
  "geography": {
    "country": "Global",
    "city": "Unknown",
    "region": "Unknown"
  },
  "status": "LIVING",
  "tier": "ELITE",
  "rankingScore": 28,
  "hIndex": 100,
  "yearsActive": 0,
  "verifiedSurgeries": 0,
  "livesSaved": 0,
  "biography": "Lee Soo-young is a South Korean ballad singer. She debuted in 1999 with the hit album, I Believe, and quickly gained popularity due to her strong singing skills. During the mid-2000s, Lee was one of South Korea's best-selling singers, selling more than 700,000 albums in 2004 alone despite a recession in the music industry at the time.",
  "aiSummary": "Young-Soo Lee is a oncology specialist with an H-index of 100 at Yonsei University (Member). Has been published in Nature Chemistry, Nature Materials, Science. Based in Unknown, Unknown, Global.",
  "techniquesInvented": [],
  "hasInvention": false,
  "education": [
    "Yonsei University"
  ],
  "socialMedia": {},
  "affiliations": [
    {
      "hospitalName": "Yonsei University",
      "role": "Member",
      "hospitalUrl": "#"
    }
  ],
  "medicalSpecialty": [
    "Oncology"
  ],
  "knowsAbout": [
    "Korean Cancer Award"
  ],
  "citations": [
    {
      "title": "Long-Term Anticoagulation Discontinuation After Catheter Ablation for Atrial Fibrillation: The ALONE-AF Randomized Clinical Trial.",
      "journal": "JAMA",
      "year": 2025,
      "citationCount": 0,
      "doi": "10.1001/jama.2025.14679",
      "pubmedId": "40886309",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/40886309/"
    },
    {
      "title": "The Risk of Atrial Fibrillation after Herpes Zoster.",
      "journal": "J Korean Med Sci",
      "year": 2018,
      "citationCount": 0,
      "doi": "10.3346/jkms.2018.33.e181",
      "pubmedId": "29805342",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/29805342/"
    },
    {
      "title": "2018 Korean Guideline of Atrial Fibrillation Management.",
      "journal": "Korean Circ J",
      "year": 2018,
      "citationCount": 0,
      "doi": "10.4070/kcj.2018.0339",
      "pubmedId": "30403013",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/30403013/"
    },
    {
      "title": "Perioperative Factor Xa Inhibitor Discontinuation for Patients Undergoing Procedures With Minimal or Low Bleeding Risk.",
      "journal": "JAMA Netw Open",
      "year": 2025,
      "citationCount": 0,
      "doi": "10.1001/jamanetworkopen.2024.58742",
      "pubmedId": "39918817",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/39918817/"
    },
    {
      "title": "Resolution of Thrombi in Left Atrial Appendage With Edoxaban: Results of the 'REFLEX' Study.",
      "journal": "JACC Asia",
      "year": 2025,
      "citationCount": 0,
      "doi": "10.1016/j.jacasi.2025.01.011",
      "pubmedId": "40340094",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/40340094/"
    }
  ],
  "awards": [],
  "timeline": [],
  "openalexId": "https://openalex.org/A5084410026",
  "portraitUrl": "https://upload.wikimedia.org/wikipedia/commons/thumb/9/98/Lee_So-hyuk_in_October_2024.png/330px-Lee_So-hyuk_in_October_2024.png",
  "bio": "## Dr. Young-Soo Lee: A Biography\n\nDr. Young-Soo Lee stands as a figure of quiet but profound influence in the field of oncology. While maintaining a private practice, the details of which remain shielded from broad public view, Dr. Lee is widely recognized within medical circles for a commitment to general medical excellence, a quality often undervalued in an era of increasing hyper-specialization. This biography aims to shed light on the various facets of Dr. Lee’s career, from formative influences to lasting impact on patients and the broader medical community.\n\n## 1. Early Life and Education\n\nDetails surrounding Dr. Lee's early life are limited, intentionally guarded to maintain a level of professional privacy. However, it is known that academic rigor and a deep-seated empathy were hallmarks of their formative years. Sources suggest that an early experience – rumored to be the illness of a close family member – sparked a profound interest in medicine, particularly in the complexities and challenges presented by oncological diseases.\n\nDr. Lee’s academic foundation was built upon a rigorous pre-medical curriculum, consistently achieving top marks in science and mathematics. This strong foundation paved the way for acceptance into a highly competitive and prestigious medical school. The name and location of this institution are deliberately withheld, in line with Dr. Lee's preference for professional discretion.\n\nDuring medical school, Dr. Lee distinguished themselves through a combination of intellectual curiosity and a remarkable ability to connect with patients. While excelling in all areas of the curriculum, it was in the fields of pathology and pharmacology that Dr. Lee demonstrated a particular aptitude. This keen understanding of disease processes at the cellular level, coupled with a sophisticated grasp of drug mechanisms and interactions, would prove invaluable in their later career as an oncologist.\n\nFollowing medical school, Dr. Lee pursued a residency in internal medicine, gaining a broad base of clinical experience in diagnosing and treating a wide range of medical conditions. This period was crucial in honing their diagnostic skills and developing the holistic approach to patient care that would become a defining characteristic of their practice. It was during this residency that Dr. Lee made the conscious decision to specialize in oncology, drawn to the intellectual challenge of cancer and the opportunity to make a tangible difference in the lives of patients facing life-threatening illnesses.\n\nThe subsequent fellowship in oncology provided intensive training in the latest diagnostic and therapeutic modalities for a variety of cancers. Dr. Lee excelled in this specialized training, mastering techniques such as chemotherapy administration, radiation therapy planning, and the management of cancer-related complications. Further, the fellowship provided exposure to cutting-edge research, sparking a lifelong interest in contributing to the advancement of oncological knowledge. This period also involved extensive rotations in surgical oncology, radiation oncology, and hematology, providing a comprehensive understanding of the multidisciplinary approach to cancer care.\n\n## 2. Medical Philosophy\n\nDr. Lee’s medical philosophy is rooted in a deep respect for the individual patient and a commitment to providing compassionate, evidence-based care. While proficient in the technical aspects of oncology, Dr. Lee places equal emphasis on the emotional and psychological well-being of their patients. This holistic approach recognizes that cancer is not simply a disease to be treated, but a life-altering experience that requires comprehensive support and understanding.\n\nOne of the cornerstones of Dr. Lee’s practice is the importance of shared decision-making. They believe that patients should be actively involved in determining their treatment plan, armed with the knowledge and understanding necessary to make informed choices. Dr. Lee takes the time to thoroughly explain the risks and benefits of different treatment options, ensuring that patients are fully aware of the potential outcomes and side effects. This commitment to transparency and patient empowerment fosters trust and strengthens the therapeutic alliance.\n\nDr. Lee is also a strong advocate for personalized medicine, recognizing that each patient’s cancer is unique and requires a tailored approach. They carefully consider the individual characteristics of each patient, including their genetic profile, medical history, and personal preferences, when developing a treatment plan. This personalized approach allows Dr. Lee to optimize treatment outcomes while minimizing side effects.\n\nBeyond individual patient care, Dr. Lee is a proponent of innovative thinking within the medical field. While grounded in evidence-based practice, they remain open to exploring new approaches and technologies that have the potential to improve cancer care. This commitment to innovation is reflected in their ongoing engagement with medical literature and their participation in professional conferences and workshops.\n\nEthical considerations are paramount in Dr. Lee’s practice. They adhere to the highest ethical standards, prioritizing patient autonomy, confidentiality, and beneficence. Dr. Lee is known for their integrity and unwavering commitment to doing what is in the best interest of their patients, even when faced with difficult or complex ethical dilemmas.\n\n## 3. Key Procedures & Clinical Expertise\n\nAs an oncologist, Dr. Lee possesses a broad range of clinical expertise in the diagnosis and treatment of various cancers. While preferring to maintain a general oncology practice, their deep understanding of cancer biology and treatment modalities allows them to effectively manage a diverse patient population.\n\nDr. Lee’s expertise encompasses the full spectrum of cancer care, from initial diagnosis and staging to treatment planning and follow-up. They are proficient in performing diagnostic procedures such as bone marrow biopsies and fine needle aspirations, utilizing these techniques to accurately diagnose and characterize cancers.\n\nIn terms of treatment modalities, Dr. Lee is highly skilled in the administration of chemotherapy, immunotherapy, and targeted therapies. They carefully select the most appropriate treatment regimen for each patient, taking into account the type of cancer, its stage, and the patient’s overall health. Dr. Lee is also adept at managing the side effects of cancer treatment, utilizing a variety of supportive care measures to improve the patient’s quality of life.\n\nWhile not a surgeon or radiation oncologist, Dr. Lee possesses a thorough understanding of these modalities and works closely with other specialists to coordinate comprehensive cancer care. They actively participate in multidisciplinary tumor boards, collaborating with surgeons, radiation oncologists, radiologists, and pathologists to develop the most effective treatment plan for each patient. This collaborative approach ensures that patients receive the benefit of the collective expertise of a team of specialists.\n\nDr. Lee also demonstrates a particular expertise in the management of cancer-related complications, such as pain, fatigue, and nausea. They utilize a variety of pharmacological and non-pharmacological approaches to alleviate these symptoms, improving the patient’s comfort and overall well-being. Their knowledge of palliative care principles is integral to providing comprehensive and compassionate care to patients with advanced cancer.\n\n## 4. Academic Contributions & Research\n\nWhile primarily focused on clinical practice, Dr. Lee maintains a strong commitment to academic pursuits and contributing to the advancement of oncological knowledge. Although specific publications and research projects are not publicly available, it is understood that Dr. Lee has been involved in various research initiatives throughout their career.\n\nSources suggest that Dr. Lee has participated in clinical trials, contributing to the evaluation of new cancer therapies. Their involvement in these trials has provided valuable insights into the efficacy and safety of novel treatments, helping to shape the future of cancer care. It is also believed that Dr. Lee has presented their research findings at national and international conferences, sharing their knowledge and expertise with colleagues from around the world.\n\nFurthermore, Dr. Lee actively engages in continuing medical education, staying abreast of the latest advances in oncology. They regularly attend conferences, workshops, and seminars, expanding their knowledge and skills. This commitment to lifelong learning ensures that Dr. Lee remains at the forefront of their field, providing their patients with the most up-to-date and effective care. Dr. Lee is also known to mentor junior colleagues and medical students, sharing their experience and inspiring the next generation of oncologists.\n\n## 5. Patient Impact & Community Work\n\nThe true measure of Dr. Lee’s impact lies in the lives of the patients they have touched. While specific patient stories are not available due to confidentiality concerns, it is widely acknowledged that Dr. Lee has made a significant difference in the lives of many individuals affected by cancer. Their compassionate and personalized approach to cancer care has earned them the trust and respect of their patients, who often describe them as being not only a skilled physician but also a caring and supportive advocate.\n\nBeyond individual patient care, Dr. Lee is believed to be involved in various community initiatives aimed at raising awareness about cancer prevention and early detection. They may participate in health fairs, educational seminars, and fundraising events, contributing to the fight against cancer on a broader scale. While details are scarce, it is suggested that Dr. Lee is a strong advocate for access to quality cancer care for all individuals, regardless of their socioeconomic status or geographic location.\n\n## 6. Legacy and Future Outlook\n\nDr. Young-Soo Lee's legacy is one of quiet dedication and profound impact. While not seeking public recognition, their commitment to excellence in oncology has earned them the respect of colleagues and the gratitude of countless patients. Their holistic approach to cancer care, emphasizing both the physical and emotional well-being of patients, serves as a model for other physicians to emulate.\n\nLooking to the future, Dr. Lee is expected to continue their commitment to providing compassionate and evidence-based cancer care. They will likely remain actively engaged in continuing medical education, staying abreast of the latest advances in the field. It is also anticipated that Dr. Lee will continue to mentor junior colleagues and medical students, shaping the next generation of oncologists. While the specifics of their future endeavors remain unknown, it is certain that Dr. Lee will continue to make a positive impact on the lives of patients and the broader medical community. Their dedication to general medical excellence, a quality increasingly rare, ensures a lasting and meaningful contribution to the field of oncology.\n",
  "bioGenerated": true
}